相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types
Laure-Anne Van Bellinghen et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2018)
Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region
Lance Jennings et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Prospective comparative study of characteristics associated with influenza A and B in adults
A. Chagvardieff et al.
MEDECINE ET MALADIES INFECTIEUSES (2018)
Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior
Jeongmin Seo et al.
VACCINE (2018)
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons
Carine Claeys et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
Edward W. Thommes et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model
L. Gerlier et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
AN ALGORITHM TO DEVELOP CORRELATED MULTIVARIATE NON-NORMAL (EG BETA, GAMMA, LOG-NORMAL) DISTRIBUTIONS TO BE USED IN PROBABILISTIC SENSITIVITY ANALYSES (PSAS)
M. Neine et al.
VALUE IN HEALTH (2017)
A systematic review of the health economic consequences of quadrivalent influenza vaccination
Pieter T. de Boer et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America
Aurelien Jamotte et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
The Korean Influenza National Immunization Program: History and Present Status
Jae-Won Yun et al.
INFECTION AND CHEMOTHERAPY (2017)
AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users
P. Vemer et al.
PHARMACOECONOMICS (2016)
Health-Adjusted Life Expectancy (HALE) in Korea: 2005-2011
Jin Yong Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
Lisa Nagy et al.
PHARMACOECONOMICS (2016)
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
Christiaan Dolk et al.
PHARMACOECONOMICS (2016)
Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service
Yong-Ho Lee et al.
DIABETES & METABOLISM JOURNAL (2016)
Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
Edward W. Thommes et al.
BMC INFECTIOUS DISEASES (2015)
Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study
Marc Baguelin et al.
BMC MEDICINE (2015)
Antiviral treatment of influenza in South Korea
Young June Choe et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives
Joon Young Song et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Clinical Manifestations of Influenza A and B in Children and Adults at a Tertiary Hospital in Korea during the 2011-2012 Season
Kyung-Wook Hong et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2015)
Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK
G. Meier et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
Ayman Chit et al.
PLOS ONE (2015)
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
Oliver Damm et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2015)
Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection
Su Su et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model
Laure-Anne Van Bellinghen et al.
PLOS ONE (2014)
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
Emma Quinn et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
Karen M. Clements et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Influenza Vaccination Coverage among Adults in Korea: 2008-2009 to 2011-2012 Seasons
Hye Jung Yang et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2014)
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
Andrea C. Tricco et al.
BMC MEDICINE (2013)
Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version) Consensus and Compromise
SeungJin Bae et al.
PHARMACOECONOMICS (2013)
The rationale for quadrivalent influenza vaccines
Christopher S. Ambrose et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Clinical Practice Guideline for Antiviral Treatment and Chemoprophylaxis of Seasonal Influenza
Won-Suk Choi et al.
INFECTION AND CHEMOTHERAPY (2012)
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions
Irina Cleemput et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2011)
INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS?
Takeru Shiroiwa et al.
HEALTH ECONOMICS (2010)
Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South Korea
Eun Young Bae et al.
VALUE IN HEALTH (2009)
Burden of viral respiratory disease hospitalizations among children in a community of Seoul, Republic of Korea, 1995-2005
Yun K. Kim et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Scott D Grosse
Expert Review of Pharmacoeconomics & Outcomes Research (2008)
National Institute for Clinical Excellence and its value judgments
MD Rawlins et al.
BRITISH MEDICAL JOURNAL (2004)
The evolution of human influenza viruses
AJ Hay et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia
JA Mauskopf et al.
PHARMACOECONOMICS (2000)
分享论文
